SE0400501D0 - Antibody purification - Google Patents

Antibody purification

Info

Publication number
SE0400501D0
SE0400501D0 SE0400501A SE0400501A SE0400501D0 SE 0400501 D0 SE0400501 D0 SE 0400501D0 SE 0400501 A SE0400501 A SE 0400501A SE 0400501 A SE0400501 A SE 0400501A SE 0400501 D0 SE0400501 D0 SE 0400501D0
Authority
SE
Sweden
Prior art keywords
cation
aromatic
solution
modal
exchanging group
Prior art date
Application number
SE0400501A
Other languages
English (en)
Swedish (sv)
Inventor
Bo-Lennart Johansson
Hans J Johansson
Anders Ljungloef
Jean-Luc Maloisel
Nicolas Thevenin
Original Assignee
Amersham Biosciences Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Biosciences Ab filed Critical Amersham Biosciences Ab
Priority to SE0400501A priority Critical patent/SE0400501D0/xx
Publication of SE0400501D0 publication Critical patent/SE0400501D0/xx
Priority to KR1020067017115A priority patent/KR101149969B1/ko
Priority to CA2552823A priority patent/CA2552823C/fr
Priority to DE602005016220T priority patent/DE602005016220D1/de
Priority to JP2007500724A priority patent/JP4776615B2/ja
Priority to NZ548127A priority patent/NZ548127A/en
Priority to EP05722174A priority patent/EP1718668B1/fr
Priority to AU2005217348A priority patent/AU2005217348B2/en
Priority to CN2005800062670A priority patent/CN1926146B/zh
Priority to PCT/SE2005/000292 priority patent/WO2005082926A1/fr
Priority to AT05722174T priority patent/ATE440858T1/de
Priority to US10/589,718 priority patent/US7385040B2/en
Priority to CN200580006276XA priority patent/CN1925898B/zh
Priority to US10/589,717 priority patent/US7750129B2/en
Priority to CA2552639A priority patent/CA2552639C/fr
Priority to AU2005216847A priority patent/AU2005216847B2/en
Priority to EP05722175A priority patent/EP1718386A1/fr
Priority to JP2007500725A priority patent/JP4848356B2/ja
Priority to KR1020067017113A priority patent/KR101150050B1/ko
Priority to NZ548126A priority patent/NZ548126A/en
Priority to PCT/SE2005/000293 priority patent/WO2005082483A1/fr
Priority to IL176635A priority patent/IL176635A/en
Priority to IL176745A priority patent/IL176745A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3847—Multimodal interactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04—Processes using organic exchangers
    • B01J39/07—Processes using organic exchangers in the weakly acidic form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE0400501A 2004-02-27 2004-02-27 Antibody purification SE0400501D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification
US10/589,718 US7385040B2 (en) 2004-02-27 2005-02-24 Antibody purification
AT05722174T ATE440858T1 (de) 2004-02-27 2005-02-24 Aufreinigung von antikírpern
CA2552823A CA2552823C (fr) 2004-02-27 2005-02-24 Purification d'anticorps
DE602005016220T DE602005016220D1 (de) 2004-02-27 2005-02-24 Aufreinigung von antikörpern
JP2007500724A JP4776615B2 (ja) 2004-02-27 2005-02-24 抗体精製
NZ548127A NZ548127A (en) 2004-02-27 2005-02-24 Method for antibody purification
EP05722174A EP1718668B1 (fr) 2004-02-27 2005-02-24 Purification d'anticorps
AU2005217348A AU2005217348B2 (en) 2004-02-27 2005-02-24 Antibody purification
CN2005800062670A CN1926146B (zh) 2004-02-27 2005-02-24 抗体纯化
PCT/SE2005/000292 WO2005082926A1 (fr) 2004-02-27 2005-02-24 Purification d'anticorps
KR1020067017115A KR101149969B1 (ko) 2004-02-27 2005-02-24 항체 정제
PCT/SE2005/000293 WO2005082483A1 (fr) 2004-02-27 2005-02-25 Procede de purification d'anticorps
CN200580006276XA CN1925898B (zh) 2004-02-27 2005-02-25 纯化抗体的工艺
US10/589,717 US7750129B2 (en) 2004-02-27 2005-02-25 Process for the purification of antibodies
CA2552639A CA2552639C (fr) 2004-02-27 2005-02-25 Procede de purification d'anticorps
AU2005216847A AU2005216847B2 (en) 2004-02-27 2005-02-25 A process for the purification of antibodies
EP05722175A EP1718386A1 (fr) 2004-02-27 2005-02-25 Procede de purification d'anticorps
JP2007500725A JP4848356B2 (ja) 2004-02-27 2005-02-25 抗体精製法
KR1020067017113A KR101150050B1 (ko) 2004-02-27 2005-02-25 항체 정제 방법
NZ548126A NZ548126A (en) 2004-02-27 2005-02-25 A process for the purification of antibodies involving addition of a second resin
IL176635A IL176635A (en) 2004-02-27 2006-06-29 Method of purification of antibodies from one or more contaminants by chromatography and a system for such purification
IL176745A IL176745A (en) 2004-02-27 2006-07-06 Process for the purification of antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification

Publications (1)

Publication Number Publication Date
SE0400501D0 true SE0400501D0 (sv) 2004-02-27

Family

ID=32067281

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0400501A SE0400501D0 (sv) 2004-02-27 2004-02-27 Antibody purification

Country Status (13)

Country Link
US (1) US7385040B2 (fr)
EP (1) EP1718668B1 (fr)
JP (1) JP4776615B2 (fr)
KR (1) KR101149969B1 (fr)
CN (2) CN1926146B (fr)
AT (1) ATE440858T1 (fr)
AU (1) AU2005217348B2 (fr)
CA (1) CA2552823C (fr)
DE (1) DE602005016220D1 (fr)
IL (1) IL176635A (fr)
NZ (1) NZ548127A (fr)
SE (1) SE0400501D0 (fr)
WO (1) WO2005082926A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
US7589183B2 (en) * 2006-11-28 2009-09-15 Bio-Rad Laboratories, Inc. Prevention of leaching of ligands from affinity-based purification systems
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
JP2010515917A (ja) * 2007-01-10 2010-05-13 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー クロマトグラフィーレジン
JP5888481B2 (ja) 2007-03-28 2016-03-22 ディーピーエックス ホールディングス ビー．ブイ． 膨張床カラムおよび使い捨て可能なクロマトグラフィー
AU2008256411B2 (en) * 2007-06-01 2013-08-22 F. Hoffmann-La Roche Ag Immunoglobulin purification
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
EP2027875A1 (fr) * 2007-08-23 2009-02-25 Octapharma AG Processus d'isolation et de purification d'une protéine cible libre de protéine de prion (PrPSC)
JP5778389B2 (ja) 2007-10-26 2015-09-16 旭化成ケミカルズ株式会社 たんぱく質の精製方法
US8158405B2 (en) * 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
US8753868B2 (en) 2008-08-04 2014-06-17 General Electric Company Method and system for selective isolation of target biological molecules in a general purpose system
US20100051554A1 (en) * 2008-08-28 2010-03-04 Dong June Ahn Molecular basket coated micro particles
EP2360183B1 (fr) * 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Méthode de purification anticorps par chromatographie a mode mixte utilisant une solution de chargement contenant arginine
CN101797493B (zh) * 2009-02-06 2014-05-21 上海抗体药物国家工程研究中心有限公司 一种在反应釜中制备亲和层析介质的方法
DE102009057993A1 (de) 2009-06-13 2011-01-20 Sartorius Stedim Biotech Gmbh Polysaccharidmatrix mit aufgepfropftem Polymer, Verfahren zu ihrer Herstellung und Verwendung
JPWO2011001963A1 (ja) * 2009-07-03 2012-12-13 旭化成ケミカルズ株式会社 多孔質基材に固定されたグラフト鎖に結合しているアミノ基及びアルキル基を有する多孔膜を用いた抗体の精製方法
WO2011049798A1 (fr) * 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Utilisation de la chromatographie en mode mixte pour la capture et la purification de produits d'anticorps de base
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
WO2011090719A2 (fr) * 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd. Purification des protéines par échange d'ions
KR101152036B1 (ko) 2010-04-27 2012-06-08 (주)셀트리온 컬럼 순환 및 시료 연속주입법을 이용한 단백질 ａ 크로마토그래피 정제 방법
WO2012015908A2 (fr) 2010-07-30 2012-02-02 Millipore Corporation Phase de chromatographie et procédé
EP2726496B1 (fr) 2011-07-01 2018-04-04 F.Hoffmann-La Roche Ag Procédé de séparation des polypeptides monomères de polypeptides agrégés
CN103906762A (zh) * 2011-10-26 2014-07-02 生物辐射实验室股份有限公司 在混合式层析中去除杀病毒剂
GB201202762D0 (en) 2012-02-17 2012-04-04 Autology Health Ltd High efficiency cell capture
CN103506079B (zh) * 2012-06-19 2016-04-06 汪志友 一种用于分离纯化抗体的介质及其制备方法
JP6335785B2 (ja) * 2012-09-03 2018-05-30 株式会社カネカ ミックスモード抗体アフィニティー分離マトリックスとそれを用いた精製方法および標的分子
KR102196230B1 (ko) 2012-09-17 2020-12-29 더블유.알. 그레이스 앤드 캄파니-콘. 크로마토그래피 매질 및 장치
EP2919902B1 (fr) 2012-11-13 2020-01-01 GE Healthcare BioProcess R&D AB Matrices d'échange d'anions multimodales
US20140238935A1 (en) 2013-02-26 2014-08-28 Natrix Separations Inc. Mixed-Mode Chromatography Membranes
AR096713A1 (es) 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
EP3048109A4 (fr) * 2013-09-17 2017-04-19 Kaneka Corporation Nouveau procédé de purification d'anticorps et anticorps obtenu au moyen de ce procédé, nouveau procédé de purification d'anticorps à l'aide d'un échangeur de cations et anticorps obtenu au moyen de ce procédé
CA2967901A1 (fr) * 2013-11-17 2015-05-21 New Proteintech Inc. Procede de preparation de materiaux chromatographiques
EP3094390B1 (fr) 2014-01-16 2021-07-07 W.R. Grace & CO. - CONN. Supports de chromatographie d'affinité et dispositifs de chromatographie
CN107847907A (zh) 2014-05-02 2018-03-27 格雷斯公司 官能化载体材料以及制备和使用官能化载体材料的方法
DE102014010353A1 (de) 2014-07-10 2016-01-14 Sartorius Stedim Biotech Gmbh Vorrichtung, Verwendung dieser Vorrichtung und Verfahren für die Stofftrennung mit verbesserter Ausnutzung der Kapazität chromatographischer Medien
EP3173783B1 (fr) 2014-07-25 2019-02-27 Asahi Kasei Medical Co., Ltd. Support de chromatographie d'échange de cations et son procédé d'utilisation
WO2016071376A2 (fr) 2014-11-06 2016-05-12 F. Hoffmann-La Roche Ag Variants du fragment fc caractérisés par une liaison fcrn modifiée et leurs procédés d'utilisation
KR102162753B1 (ko) 2014-12-08 2020-10-07 이엠디 밀리포어 코포레이션 혼합층 이온 교환 흡착제
KR102566292B1 (ko) 2015-06-05 2023-08-10 더블유.알. 그레이스 앤드 캄파니-콘. 흡착성 바이오프로세싱 정화제와 이의 제조 및 사용 방법
JP2019070528A (ja) * 2016-02-26 2019-05-09 Jsr株式会社 多孔質担体、アフィニティクロマトグラフィー用多孔質担体、標的物の精製方法、及び抗体
CN108883414B (zh) * 2016-04-29 2021-06-01 建奥迪斯有限公司 用于分子回收的方法和组件
MY196321A (en) 2016-08-16 2023-03-24 Regeneron Pharma Methods for Quantitating Individual Antibodies From a Mixture
WO2018081203A1 (fr) 2016-10-25 2018-05-03 Regeneron Pharmaceuticals, Inc. Procédés et systèmes d'analyse de données de chromatographie
WO2018187074A1 (fr) 2017-04-03 2018-10-11 Immunomedics, Inc. Administration par voie sous-cutanée de conjugués anticorps-médicament à titre de thérapie anticancéreuse
CN111818980B (zh) * 2018-03-08 2022-10-11 生物辐射实验室股份有限公司 阴离子交换-疏水混合模式色谱树脂
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
EP3816177A4 (fr) * 2018-06-29 2021-12-01 Mitsubishi Chemical Corporation Procédé d'isolement de polypeptide, procédé de production de polypeptide et appareil de purification de polypeptide
TW202005694A (zh) 2018-07-02 2020-02-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
US11896969B2 (en) 2019-09-05 2024-02-13 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204810L (sv) 1982-08-23 1984-02-24 Pharmacia Fine Chemicals Ab Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4983722A (en) 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
GB9519197D0 (en) * 1995-09-20 1995-11-22 Affinity Chromatography Ltd Novel affinity ligands and their use
US6117996A (en) * 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
CA2264177C (fr) * 1996-08-30 2015-03-17 Upfront Chromatography A/S Isolement d'immunoglobulines
SE0002688D0 (sv) 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands
AU2002235795A1 (en) * 2000-12-31 2002-07-16 Amersham Biosciences Ab A method for the manufacture of compositions containing low concentrations of salts
JP2004517310A (ja) * 2001-01-05 2004-06-10 プロ・ケム インク 精製器具及び方法
SE0103084D0 (sv) 2001-09-14 2001-09-14 Amersham Pharm Biotech Ab Generation of ion exchange media
DE10155984A1 (de) 2001-11-15 2003-05-28 Boehringer Ingelheim Pharma Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices
ATE417858T1 (de) * 2002-02-05 2009-01-15 Genentech Inc Proteinaufreinigung
EP1601697B1 (fr) 2003-02-28 2007-05-30 Lonza Biologics plc Purification d'anticorps par chromatographie d'affinité sur Proteine A et chromatographie par echange d'ions

Also Published As

Publication number Publication date
EP1718668A1 (fr) 2006-11-08
CN1925898A (zh) 2007-03-07
CA2552823A1 (fr) 2005-09-09
ATE440858T1 (de) 2009-09-15
DE602005016220D1 (de) 2009-10-08
AU2005217348B2 (en) 2011-03-31
CN1926146B (zh) 2010-06-16
JP4776615B2 (ja) 2011-09-21
AU2005217348A1 (en) 2005-09-09
WO2005082926A1 (fr) 2005-09-09
US7385040B2 (en) 2008-06-10
EP1718668B1 (fr) 2009-08-26
US20070112178A1 (en) 2007-05-17
CN1925898B (zh) 2010-09-01
NZ548127A (en) 2009-09-25
CA2552823C (fr) 2013-11-19
KR20070001969A (ko) 2007-01-04
KR101149969B1 (ko) 2012-07-05
CN1926146A (zh) 2007-03-07
IL176635A0 (en) 2006-10-31
JP2008505851A (ja) 2008-02-28
IL176635A (en) 2011-07-31

Similar Documents

Publication Publication Date Title
SE0400501D0 (sv) Antibody purification
WO2006138737A3 (fr) Procedes de purification d'anticorps anti a beta
EA200970230A1 (ru) СПОСОБ ОЧИСТКИ Fc-СЛИТЫХ БЕЛКОВ
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
WO2004024866A3 (fr) Purification de proteines
EA200702210A1 (ru) Способ очистки белков
DE69932944D1 (de) Kolonne und mit dieser durchgeführtes chromatographisches verfahren
EP1568710A3 (fr) Procédé de purification des anticorps
WO2008087184A3 (fr) Procédé pour la purification de protéines contenant fc
WO2002088306A3 (fr) Anticorps humanises
WO2003066662A3 (fr) Purification de proteines
DE60229051D1 (de) Humanisierte antikörper
EA200970231A1 (ru) СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ
FR2892820B1 (fr) Procede magnetique d'immunodiagnostic pour la mise en evidence de complexe anticorps/antigene, en particulier de groupe sanguin
DE602004006157D1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
SE0300791D0 (sv) Use of ph-responsive polymers
ATE529433T1 (de) Verfahren zur reinigung eines il-18-bindenden proteins
ATE499384T1 (de) Multimere fc-rezeptor-polypeptide
ATE417056T1 (de) Verfahren zur proteinreinigung
DE602004007250D1 (de) Verfahren für volumen mit hohem durchsatz bei der fraktionierung von biomolekülen durch chromatographische systeme
PT1115745E (pt) Purificacao de fibrinogenio de fluidos por precipitacao e cromatografia de interaccao hidrofobica
SE0502649L (sv) Aktiverad fast stödfas och metod
MY157846A (en) Process for the purification of fc-containing proteins
SE0402558D0 (sv) A process for the purification of antibodies
JP5067917B2 (ja) Ａｄａｍｔｓ１３の分離精製方法